No Cover Image

Journal article 11 views 13 downloads

Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register

Afagh Garjani, Rod Middleton Orcid Logo, Richard Nicholas, Nikos Evangelou

Neurology - Neuroimmunology Neuroinflammation, Volume: 9, Issue: 1, Start page: e1118

Swansea University Author: Rod Middleton Orcid Logo

  • 59132.pdf

    PDF | Version of Record

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

    Download (366.52KB)

Abstract

To understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) and to determine its predictors, including patients' pre-COVID-19 physical and mental health status.<h4>Methods</h4>This prospective and longitudinal cohort stud...

Full description

Published in: Neurology - Neuroimmunology Neuroinflammation
ISSN: 2332-7812 2332-7812
Published: Ovid Technologies (Wolters Kluwer Health) 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa59132
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: To understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) and to determine its predictors, including patients' pre-COVID-19 physical and mental health status.<h4>Methods</h4>This prospective and longitudinal cohort study recruited patients with MS who reported COVID-19 from March 17, 2020, to March 19, 2021, as part of the United Kingdom MS Register (UKMSR) COVID-19 study. Participants used online questionnaires to regularly update their COVID-19 symptoms, recovery status, and duration of symptoms for those who fully recovered. Questionnaires were date stamped for estimation of COVID-19 symptom duration for those who had not recovered at their last follow-up. The UKMSR holds demographic and up-to-date clinical data on participants as well as their web-based Expanded Disability Status Scale (web-EDSS) and Hospital Anxiety and Depression Scale (HADS) scores. The association between these factors and recovery from COVID-19 was assessed using multivariable Cox regression analysis.<h4>Results</h4>Of the 7,977 patients with MS who participated in the UKMSR COVID-19 study, 599 reported COVID-19 and prospectively updated their recovery status. Twenty-eight hospitalized participants were excluded. At least 165 participants (29.7%) had long-standing COVID-19 symptoms for ≥4 weeks and 69 (12.4%) for ≥12 weeks. Participants with pre-COVID-19 web-EDSS scores ≥7, participants with probable anxiety and/or depression (HADS scores ≥11) before COVID-19 onset, and women were less likely to report recovery from COVID-19.<h4>Discussion</h4>Patients with MS are affected by postacute sequelae of COVID-19. Preexisting severe neurologic impairment or mental health problems appear to increase this risk. These findings can have implications in tailoring their post-COVID-19 rehabilitation.
College: Swansea University Medical School
Funders: Multiple Sclerosis Society Grant: 131
Issue: 1
Start Page: e1118